Global Impact of COVID-19 on Colorectal Cancer Screening: Current Insights and Future Directions
The coronavirus disease 2019 (COVID-19) pandemic has brought significant challenges to many aspects of healthcare delivery since the first reported case in early December 2019. Once in the body, SARS-CoV-2 can spread to other digestive organs, such as the liver, because of the presence of ACE2 recep...
Main Authors: | Jonathan Kopel, Bojana Ristic, Gregory L. Brower, Hemant Goyal |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-01-01
|
Series: | Medicina |
Subjects: | |
Online Access: | https://www.mdpi.com/1648-9144/58/1/100 |
Similar Items
-
A Review of the Impact of the COVID-19 Pandemic on Colorectal Cancer Screening: Implications and Solutions
by: Suneha Sundaram, et al.
Published: (2021-11-01) -
Population Screening for Colorectal Cancer Means Getting FIT: The Past, Present, and Future of Colorectal Cancer Screening Using the Fecal Immunochemical Test for Hemoglobin (FIT)
Published: (2014-03-01) -
Optimization of multiplex PCR composition to screen for SARS-CoV-2 variants of concern
by: Maya Savira, et al.
Published: (2021-12-01) -
The impact of ACE2 and co‐factors on SARS‐CoV‐2 infection in colorectal cancer
by: Shuwei Li, et al.
Published: (2022-07-01) -
Effectiveness and implementation of mPATH™-CRC: a mobile health system for colorectal cancer screening
by: Anna C. Snavely, et al.
Published: (2023-04-01)